DOI QR코드

DOI QR Code

신생아 혈액 응고질환: 출혈 경향을 보이는 신생아에 대한 진단적 접근

Neonatal Coagulation Disorder: Diagnostic Approaches for Bleeding Neonates

  • 김천수 (계명대학교 의과대학 소아청소년과학교실)
  • Kim, Chun-Soo (Department of Pediatrics, Keimyung University School of Medicine)
  • 발행 : 2011.05.31

초록

All newborn infants with clinically significant bleeding should be evaluated for a hemostatic deficit. Medical history should include the following data: familial bleeding disorders, maternal illness and medication, age of bleeding onset, and prophylactic administration of vitamin K. The first essential step for evaluating bleeding neonates is determining whether the baby is sick or well. The physician should also evaluate the extent of the bleeding, features of bleeding lesions, and other abnormal findings from the physical examination. Skeletal anomalies may provide diagnostic clues. Depending on the clinical features and results of screening tests, other tests including coagulation factors may be useful for determining the diagnosis. All laboratory results must be considered in the context of age-related reference values. The platelet function analyzer provides a promising alternative to bleeding time. Fibrin degradation products and D-dimers are used for screening and specially testing fibrinolytic activity, respectively. The Apt test may help to rule out factors derived from maternal blood. Radiologic imaging studies are important because asymptomatic intracranial hemorrhages are common in neonates.

키워드

참고문헌

  1. Kuhle S, Mitchell L, Massicotte P, Andrew M. Hemostatic disorders of the newborn. In: Taeusch HW, Ballard RA, Gleason CA. editors. Avery's diseases of the newborn. 8th ed. Philadelphia: Elsevier Saunders, 2005:1145-79.
  2. Chalmers EA. Neonatal coagulation problems. Arch Dis Child Fetal Neonatal Ed 2004;89:F475-8. https://doi.org/10.1136/adc.2004.050096
  3. Korones SB, Bada-Ellzey HS. Neonatal decision making. St. Louis: Mosby, 1993:192-3.
  4. Goorin AM, Neufeld E. Bleeding. In: Cloherty JP, Eichenwald EC, Stark AR, editors. Manual of neonatal care. 5th ed. Philadelphia: Lippinciott William & Wilkins, 2004:468-74.
  5. Abshire TC. An approach to the diagnosis and treatment of bleeding disorders in infants. Int J Hematol 2002;76 Suppl 2:265-70.
  6. Ogundeyi MM, Ogunlesi TA. Approach to the management of a bleeding neonate. Niger J Med 2009;18:238-43.
  7. Pramanik AK. Bleeding disorders in neonates. Pediatr Rev 1992; 13:163-73. https://doi.org/10.1542/pir.13-5-163
  8. Andrew M, Paes B, Johnston M. Development of the hemostatic system in the neonate and young infant. Am J Pediatr Hematol Oncol 1990;12:95-104. https://doi.org/10.1097/00043426-199021000-00019
  9. Andrew M, Vegh P, Johnston M, Bowker J, Ofosu F, Mitchell L. Maturation of the hemostatic system during childhood. Blood 1992;80:1998-2005.
  10. Roberts I, Stanworth S, Murray NA. Thrombocytopenia in the neonate. Blood Rev 2008;22:173-86. https://doi.org/10.1016/j.blre.2008.03.004
  11. Bussel JB, Zabusky MR, Berkowitz RL, McFarland JG. Fetal alloimmune thrombocytopenia. N Engl J Med 1997;337:22-6. https://doi.org/10.1056/NEJM199707033370104
  12. Sutor AH, von Kries R, Cornelissen EA, McNinch AW, Andrew M. Vitamin K deficiency bleeding (VKDB) in infancy. Thromb Haemost 1999;81:456-61.
  13. Saxonhouse MA, Manco-Johnson MJ. The evaluation and management of neonatal coagulation disorders. Semin Perinatol 2009; 33:52-65. https://doi.org/10.1053/j.semperi.2008.10.007
  14. Yuen P. The bleeding newborn. J Hong Kong Med Assoc 1987;39: 83-7.
  15. Sheth S. Hematology. In: Polin RA, Spitzer AR, editors. Fetal and neonatal secrets. 2nd ed. Philadelphia: Mosby Elsevier, 2007: 259- 91.
  16. Scott JP. Montgomery RR. Hemorrhagic and thrombitic diseases. In : Kliegman RM, Behrman RE, Jenson HB, Stanton BF, editors. Nelson textbook of pediatrics. 18th ed. Philadelphia: Saunders, 2007:2060-6.
  17. Cariappa R, Wilhite TR, Parvin CA, Luchtman-Jones L. Comparison of PFA-100 and bleeding time testing in pediatric patients with suspected hemorrhagic problems. J Pediatr Hematol Oncol 2003;25:474-9. https://doi.org/10.1097/00043426-200306000-00009
  18. Carcao MD, Blanchette VS, Dean JA, He L, Kern MA, Stain AM, et al. The Platelet Function Analyzer (PFA-100): a novel in-vitro system for evaluation of primary haemostasis in children. Br J Haematol 1998;101:70-3. https://doi.org/10.1046/j.1365-2141.1998.00656.x
  19. Favaloro EJ. Clinical application of the PFA-100. Curr Opin Hematol 2002;9:407-15. https://doi.org/10.1097/00062752-200209000-00004
  20. Israels SJ, Cheang T, McMillan-Ward EM, Cheang M. Evaluation of primary hemostasis in neonates with a new in vitro platelet function analyzer. J Pediatr 2001;138:116-9. https://doi.org/10.1067/mpd.2001.109794
  21. Polack B, Pouzol P, de Mazancourt P, Gay V, Hanss M. Is primary prophylaxis required in afibrinogenemia? Transfusion 2010;50:1401- 3. https://doi.org/10.1111/j.1537-2995.2010.02612.x
  22. Ataoglu E, Duru NS, Celkan T, Civilibal M, Yavuz SC, Elevli M, et al. Spontaneous intracranial bleeding in a neonate with congenital afibrinogenemia. Blood Coagul Fibrinolysis 2010;21:592-4. https://doi.org/10.1097/MBC.0b013e32833a06e2
  23. Adam SS, Key NS, Greenberg CS. D-dimer antigen: current concepts and future prospects. Blood 2009;113:2878-87. https://doi.org/10.1182/blood-2008-06-165845
  24. El Beshlawy A, Alaraby I, Abou Hussein H, Abou-Elew HH, Mohamed Abdel Kader MS. Study of protein C, protein S, and antithrombin III in newborns with sepsis. Pediatr Crit Care Med 2010;11:52-9. https://doi.org/10.1097/PCC.0b013e3181c59032
  25. Jo JH, Oh CK, Kim MB, Jang HS, Kwon KS. A case of neonatal purpura fulminans due to a homozygous protein C deficiency. Korean J Dermatol 2002;40:38-43.
  26. Zenciroglu A, Ipek MS, Aydin M, Kara A, Okumus N, Kilic M. Purpura fulminans in a newborn infant with galactosemia. Eur J Pediatr 2010;169:903-6. https://doi.org/10.1007/s00431-009-1121-y
  27. Looney CB, Smith JK, Merck LH, Wolfe HM, Chescheir NC, Hamer RM, et al. Intracranial hemorrhage in asymptomatic neonates: prevalence on MR images and relationship to obstetric and neonatal risk factors. Radiology 2007;242:535-41.
  28. Huppi PS, Gressens P. The central nervous system. In: Martin RJ, Fanaroff AA, Walsh MC, editors. Fanaroff and Martin's neonatalperinatal medicine: diseases of the fetus and infant. 8th ed. St Louis: Mosby, 2006:883-1033.
  29. Blankenberg FG, Loh NN, Bracci P, D'Arceuil HE, Rhine WD, Norbash AM, et al. Sonography, CT, and MR imaging: a prospective comparison of neonates with suspected intracranial ischemia and hemorrhage. AJNR Am J Neuroradiol 2000;21:213-8.
  30. Kuusela AL, Maki M, Ruuska T, Laippala P. Stress-induced gastric findings in critically ill newborn infants: frequency and risk factors. Intensive Care Med 2000;26:1501-6. https://doi.org/10.1007/s001340051346
  31. Maloney J, Nowak-Wegrzyn A. Educational clinical case series for pediatric allergy and immunology: allergic proctocolitis, food protein-induced enterocolitis syndrome and allergic eosinophilic gastroenteritis with protein-losing gastroenteropathy as manifestations of non-IgE-mediated cow's milk allergy. Pediatr Allergy Immunol 2007;18:360-7. https://doi.org/10.1111/j.1399-3038.2007.00561.x
  32. Bae WT, Yeom JS, Park ES, Seo JH, Lim JY, Park CH, et al. Bleeding due to vitamin K deficiency as presenting symptom of cholestasis. Korean J Pediatr Gastroenterol Nutr 2005;8:257-62.